TA
BSX icon

Tiedemann Advisors’s Boston Scientific BSX Stock Holding History

Tiedemann Advisors’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-38,570
Closed -$1.48M – 308
2019
Q1 		$1.48M Buy
38,570
+58
+0.2% +$2.21K 0.07% 163
2018
Q4 		$1.36M Buy
+38,512
New +$1.4M 0.07% 166

Other funds holding BSX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BG
Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

Tiedemann Advisors's BSX Position: Q2 2019 in Review

Tiedemann Advisors sold out of Boston Scientific (BSX) in Q2 2019, closing a stake of 38,570 shares — an estimated $1.48M sold.

Tiedemann Advisors first reported a position in BSX in Q4 2018 and held it in 2 quarters. The position peaked at $1.48M in Q1 2019. 757 funds tracked by Wall St. Rank hold BSX as of Q2 2019.

  • Tiedemann Advisors reported no remaining Boston Scientific position as of Q2 2019 after selling out during the quarter.
  • Tiedemann Advisors sold 38,570 Boston Scientific shares in Q2 2019, an estimated $1.48M.
  • Tiedemann Advisors first reported a position in Boston Scientific in Q4 2018 and held it in 2 quarters.
  • Tiedemann Advisors's Boston Scientific position peaked at $1.48M in Q1 2019.
  • 757 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2019.

Based on Tiedemann Advisors's 13F filing for Q2 2019, filed 13 Aug 2019.